Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H.S. Quah
P2.13-21 MET Addiction Can Be Circumvented Through EGFR Inhibition via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLCX.
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
Acquired Resistance Mechanisms to Combination Met-Tki/Egfr-Tki Exposure in Met-Amplified EGFR-TKI–Resistant Lung Adenocarcinoma Harboring an Activating EGFR Mutation
Molecular Cancer Therapeutics
Cancer Research
Oncology
MET-EGFR Dimerization in Lung Adenocarcinoma Is Dependent on EGFR Mtations and Altered by MET Kinase Inhibition
PLoS ONE
Multidisciplinary
Triple Inhibition of EGFR, Met, and VEGF Suppresses Regrowth of HGF-Triggered, Erlotinib-Resistant Lung Cancer Harboring an EGFR Mutation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Inhibition of EGFR Induces a C-Met-Driven Stem Cell Population in Glioblastoma
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
Urea Cycle Sustains Cellular Energetics Upon EGFR Inhibition in EGFR Mutant NSCLC
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
EGFR Status in Mesothelioma: Possible Implications for the Efficacy of Anti-Egfr and Anti-Met Therapies
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Tumors Resistant to EGFR Inhibitors Can Arise via Different Mechanisms
Cancer Discovery
Oncology
AXL Circumvents PI3K Inhibition by Activating EGFR-PKC-mTOR Signaling
Cancer Discovery
Oncology
The Persistent Promise of Combining HGF/MET and EGFR Inhibition in Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
